{"id":"https://openalex.org/W1991237014","doi":"https://doi.org/10.1158/1538-7445.am2011-1795","title":"Abstract 1795: Therapy assessment of a novel anti-EMMPRIN antibody and gemcitabine in an orthotopic pancreatic-tumor murine model by FDG PET/CT imaging","display_name":"Abstract 1795: Therapy assessment of a novel anti-EMMPRIN antibody and gemcitabine in an orthotopic pancreatic-tumor murine model by FDG PET/CT imaging","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W1991237014","doi":"https://doi.org/10.1158/1538-7445.am2011-1795","mag":"1991237014"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-1795","doi":"https://doi.org/10.1158/1538-7445.am2011-1795","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-1795","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101058955","display_name":"Nemil A. Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nemil Shah","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109183545","display_name":"Guihua Zhai","orcid":"https://orcid.org/0009-0005-1023-0824","observed_orcids":["https://orcid.org/0009-0005-1023-0824"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guihua Zhai","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010873924","display_name":"Joseph A. Knowles","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Knowles","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058987373","display_name":"Cecil R. Stockard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cecil Stockard","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076077003","display_name":"William E. Grizzle","orcid":"https://orcid.org/0000-0001-9245-0401","observed_orcids":["https://orcid.org/0000-0001-9245-0401"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Grizzle","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103430976","display_name":"Naomi S. Fineberg","orcid":"https://orcid.org/0000-0003-1158-6900","observed_orcids":["https://orcid.org/0000-0003-1158-6900"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naomi Fineberg","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101777619","display_name":"Tong Zhou","orcid":"https://orcid.org/0000-0002-9618-7011","observed_orcids":["https://orcid.org/0000-0002-9618-7011"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tong Zhou","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040167645","display_name":"Kurt R. Zinn","orcid":"https://orcid.org/0000-0001-7463-4741","observed_orcids":["https://orcid.org/0000-0001-7463-4741"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kurt Zinn","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086275218","display_name":"Eben Lloyd Rosenthal","orcid":"https://orcid.org/0000-0003-0294-5203","observed_orcids":["https://orcid.org/0000-0003-0294-5203"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eben Rosenthal","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025856009","display_name":"Hyunki Kim","orcid":"https://orcid.org/0000-0003-2292-5584","observed_orcids":["https://orcid.org/0000-0003-2292-5584","https://orcid.org/0000-0003-0809-2141"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hyunki Kim","raw_affiliation_strings":["1Univ. of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Univ. of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I32389192"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"1795","last_page":"1795"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.6464999914169312,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.6464999914169312,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.19120000302791595,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.09960000216960907,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/emmprin","display_name":"EMMPRIN","score":0.9760000109672546},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9100000262260437},{"id":"https://openalex.org/keywords/orthotopic-tumor-model","display_name":"orthotopic tumor model","score":0.8450000286102295},{"id":"https://openalex.org/keywords/mia-paca-2-cells","display_name":"MIA PaCa-2 cells","score":0.843999981880188},{"id":"https://openalex.org/keywords/18f-fdg-pet-ct","display_name":"18F-FDG PET/CT","score":0.8920000195503235},{"id":"https://openalex.org/keywords/therapy-response-assessment","display_name":"therapy response assessment","score":0.47699999809265137},{"id":"https://openalex.org/keywords/tumor-volume","display_name":"tumor volume","score":0.35600000619888306},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.7760000228881836},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7570000290870667},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7129999995231628},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8666074275970459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6984176635742188},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.6802355051040649},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6177259087562561},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5592930912971497},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.4903993606567383},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4510476291179657},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.4417315721511841},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.435838907957077},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.4274403750896454},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.42150112986564636},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2578110694885254},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2568976879119873},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24336346983909607},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12250995635986328},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0676858127117157},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-1795","doi":"https://doi.org/10.1158/1538-7445.am2011-1795","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-1795","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2014234398","https://openalex.org/W1966767054","https://openalex.org/W7097738438","https://openalex.org/W2110295073","https://openalex.org/W2016211440","https://openalex.org/W2894129104","https://openalex.org/W2308885344","https://openalex.org/W207210197","https://openalex.org/W2888939640","https://openalex.org/W7145858409"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"To":[2],"evaluate":[3],"a":[4],"novel":[5],"monoclonal":[6],"antibody":[7],"targeting":[8],"human":[9,37],"EMMPRIN":[10],"with/without":[11],"gemcitabine":[12,33,120,417],"in":[13,30,46,199,238,382],"an":[14],"orthotopic":[15,56,389],"pancreatic-tumor":[16],"model":[17],"by":[18,42,180,396],"sequential":[19],"18F-FDG":[20,135],"PET/CT":[21,136,426],"imaging.":[22],"Methods:":[23],"Cytotoxicity":[24],"of":[25,52,155,194,204,215,226,246,276,284,299,323,331,337,346,365,373,388,413,425,440,445],"anti-EMMPRIN":[26,81,123,181,414],"mAb":[27,82,86,124,182,228],"alone":[28,183],"or":[29,184],"combination":[31,398],"with":[32,78,115,185,401,416,427],"was":[34,60,90,100,138,229,279,292,326,340,358,368,380,393],"measured":[35],"for":[36,131,141,410,418,449],"pancreatic":[38,390,419],"(MIA":[39],"PaCa-2)":[40],"cells":[41],"ATPLite":[43,173],"assay.":[44],"For":[45],"vivo":[47],"animal":[48],"study,":[49],"six":[50],"groups":[51,68,156,247,287,295,300,332],"SCID":[53],"mice":[54],"bearing":[55],"MIA":[57],"PaCa-2":[58],"tumors":[59,154],"used":[61],"at":[62,92,102,160,252,262,272,309,319],"21":[63,254],"days":[64],"after":[65,95,105],"cell":[66,363,384,404],"implantation;":[67],"1":[69,206],"and":[70,83,126,146,163,165,202,210,221,240,259,265,269,306,312,316,335,355,422],"2":[71,132,217],"(n=5":[72],"per":[73,110],"group)":[74,111],"were":[75,112,151,158,168,207,218,236,255,302],"i.v.":[76],"injected":[77,114],"Tc-99m":[79],"labeled":[80],"isotype":[84],"control":[85],"respectively.":[87],"SPECT/CT":[88],"imaging":[89,137,188],"conducted":[91],"4":[93],"hours":[94,104],"injection,":[96],"while":[97,134,213,233,289,377],"biodistribution":[98],"analysis":[99],"followed":[101],"24":[103],"injection.":[106],"Groups":[107],"3-6":[108,157,248,301],"(n=6":[109],"i.p.":[113],"PBS":[116],"(served":[117],"as":[118],"control),":[119],"(120mg/kg":[121],"BW),":[122],"(0.2mg),":[125],"combination,":[127],"respectively,":[128,212],"twice":[129],"weekly":[130,140],"weeks,":[133],"applied":[139],"3":[142,348,375],"weeks.":[143],"Intratumoral":[144,243],"SUVmean":[145,244,354,387],"tumor-volume":[147,356],"changes":[148,245,298,357],"during":[149],"therapy":[150,415],"quantified.":[152],"All":[153],"collected":[159],"day":[161,253,263,273,310,320],"35,":[162],"Ki-67":[164],"TUNEL":[166],"staining":[167],"implemented.":[169],"Results:":[170],"In":[171],"vitro":[172],"assay":[174],"demonstrated":[175],"only":[176],"modest":[177],"killing":[178],"efficacy":[179],"gemcitabine.":[186],"SPECT":[187],"showed":[189],"the":[190,285,397,423,441,446],"specific":[191],"tumor":[192,203,224,391],"uptake":[193,225],"Tc-99m-anti-EMMPRIN":[195,227],"mAb.":[196],"The":[197,350],"%ID/g":[198],"liver,":[200],"blood,":[201],"group":[205,216,277,324,338,347,366,374],"9.1\u00b11.3,":[208],"13.4\u00b13.0,":[209],"27.6\u00b13.2":[211],"those":[214,251,283,330],"9.2\u00b12.2,":[219],"10.8\u00b11.3,":[220],"5.8\u00b11.7":[222],"respectively;":[223],"significantly":[230,280,327,342,369,394],"higher":[231],"(p<0.001),":[232],"no":[234,290,378],"differences":[235],"detected":[237,293,381],"liver":[239],"blood":[241],"values.":[242],"relative":[249],"to":[250,429],"35\u00b113,":[256],"-19\u00b119,":[257],"25\u00b126,":[258],"-26\u00b113%":[260],"respectively":[261,271,308,318],"28,":[264,311],"134\u00b156,":[266],"60\u00b132,":[267],"43\u00b130,":[268],"-25\u00b116%":[270],"35;":[274,321],"that":[275,322,336,345,372],"6":[278,325,367],"lower":[281,328,343,370],"than":[282,329,344,371],"other":[286],"(p<0.05),":[288,334],"difference":[291,379],"among":[294],"3-5.":[296],"Tumor-volume":[297],"111\u00b124,":[303],"72\u00b126,":[304],"83\u00b127,":[305],"3\u00b18%":[307],"399\u00b148,":[313],"275\u00b157,":[314],"204\u00b134,":[315],"35\u00b18%":[317],"3-5":[333],"5":[339],"also":[341],"(p=0.042).":[349],"correlation":[351],"between":[352],"intratumoral":[353],"statistically":[359],"significant":[360],"(p=0.002).":[361],"Proliferating":[362],"density":[364],"(p=0.008),":[376],"apoptotic":[383],"densities.":[385],"Conclusions:":[386],"xenografts":[392],"decreased":[395],"therapy,":[399],"consistent":[400],"reduced":[402],"proliferating":[403],"density.":[405],"These":[406],"data":[407],"provide":[408],"support":[409],"clinical":[411],"studies":[412],"cancer":[420],"treatment,":[421],"application":[424],"FDG":[428],"monitor":[430],"efficacy.":[431],"Citation":[432],"Format:":[433],"{Authors}.":[434],"{Abstract":[435],"title}":[436],"[abstract].":[437],"In:":[438],"Proceedings":[439],"102nd":[442],"Annual":[443],"Meeting":[444],"American":[447],"Association":[448],"Cancer":[450,460],"Research;":[451],"2011":[452],"Apr":[453],"2-6;":[454],"Orlando,":[455],"FL.":[456],"Philadelphia":[457],"(PA):":[458],"AACR;":[459],"Res":[461],"2011;71(8":[462],"Suppl):Abstract":[463],"nr":[464],"1795.":[465],"doi:10.1158/1538-7445.AM2011-1795":[466]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-06-24T00:00:00"}